DEUTSCHE BANK AG\ - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 40 filers reported holding APREA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$461,000
-2.3%
94,386
+1.9%
0.00%
Q1 2021$472,000
+1648.1%
92,593
+1546.1%
0.00%
Q4 2020$27,000
-71.0%
5,625
+45.3%
0.00%
Q3 2020$93,000
-31.6%
3,870
+10.0%
0.00%
Q2 2020$136,000
+74.4%
3,518
+57.1%
0.00%
Q1 2020$78,000
-27.8%
2,239
-5.6%
0.00%
Q4 2019$108,0002,3710.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,147,0002.04%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$205,0000.33%
Quantamental Technologies LLC 13,752$67,0000.06%
Redmile Group, LLC 694,918$3,391,0000.05%
PDT Partners, LLC 124,234$606,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 353,926$1,727,0000.04%
Virtu Financial LLC 41,142$201,0000.02%
Walleye Capital LLC 98,931$483,0000.02%
SG Americas Securities, LLC 598,395$2,920,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 156,678$765,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders